This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Bhaskar Rege: Innovator in Pharmaceutical Composition
Introduction
Bhaskar Rege is a notable inventor based in Woodcliff Lake, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on PDE9 inhibitors. His expertise and dedication to research have led to the development of a unique pharmaceutical composition.
Latest Patents
Bhaskar Rege holds a patent for a pharmaceutical composition comprising a PDE9 inhibitor. The specific compound detailed in his patent is (S)-7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-(tetrahydrofuran-3-yl)-1H-pyrazolo[4,3-c]quinolin-4(5H)-one or pharmaceutically acceptable salts thereof. This invention represents a significant advancement in the treatment options available for various medical conditions.
Career Highlights
Rege is currently associated with Eisai R&D Management Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapies that can improve patient outcomes.
Collaborations
Throughout his career, Bhaskar has collaborated with esteemed colleagues, including Edgar Schuck and Robert Lai. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Bhaskar Rege's contributions to the field of pharmaceuticals, particularly through his patent on PDE9 inhibitors, highlight his role as a key innovator. His work continues to influence the development of new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile